Yoshinao Muro Selected Research

Dermatomyositis (Dermatopolymyositis)

11/2022	Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trial.
2/2022	Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA.
6/2021	Autoantibody profiles in patients' sera associated with distribution patterns of dermatomyositis skin symptoms.
1/2021	Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
10/2020	Clinical and serological features of dermatomyositis and systemic lupus erythematosus patients with autoantibodies to ADAR1.
12/2019	Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
10/2019	Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis.
9/2019	Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.
11/2018	Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.
1/2018	Intramuscular haemorrhage in a patient with dermatomyositis and anti-TIF1γ antibodies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshinao Muro Research Topics

Disease

28	Dermatomyositis (Dermatopolymyositis) 11/2022 - 09/2010
16	Myositis (Idiopathic Inflammatory Myopathies) 02/2022 - 09/2010
12	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 01/2011
11	Polymyositis 11/2022 - 06/2013
9	Neoplasms (Cancer) 11/2022 - 08/2010
8	Systemic Scleroderma (Systemic Sclerosis) 11/2022 - 04/2009
8	Melanoma (Melanoma, Malignant) 01/2021 - 09/2010
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 10/2004
6	Autoimmune Diseases (Autoimmune Disease) 03/2015 - 11/2004
5	Pemphigus (Pemphigus Vulgaris) 10/2020 - 01/2013
4	Rheumatic Diseases (Rheumatism) 11/2022 - 01/2013
4	Inflammation (Inflammations) 01/2022 - 08/2013
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2018 - 02/2005
4	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2014 - 09/2009
3	Muscular Diseases (Myopathy) 02/2022 - 10/2016
3	Localized Scleroderma (Morphea) 02/2021 - 01/2004
3	Amyopathic dermatomyositis 01/2018 - 01/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2013 - 09/2009
3	Atopic Dermatitis (Atopic Eczema) 09/2011 - 11/2004
2	Disease Progression 05/2022 - 04/2015
2	Bronchiolitis Obliterans 10/2020 - 08/2020
2	Chilblain lupus 1 10/2019 - 12/2012
2	Rheumatoid Arthritis 01/2018 - 07/2014
2	Mixed Connective Tissue Disease (MCTD) 09/2017 - 05/2009
2	Alopecia (Baldness) 12/2016 - 11/2004
2	Ulcer 12/2016 - 04/2009
2	Necrosis 10/2016 - 04/2009
2	Erythema 08/2014 - 10/2004
2	Idiopathic Pulmonary Fibrosis 06/2014 - 02/2014
1	Idiopathic Interstitial Pneumonias 11/2022
1	Raynaud Disease (Raynaud's Disease) 11/2022
1	Pericarditis 02/2022
1	Leukoencephalopathies 02/2022
1	Cerebral Infarction 02/2022
1	Fever (Fevers) 02/2022
1	Female Infertility 11/2021
1	Hidradenitis Suppurativa 06/2021
1	Crohn Disease (Crohn's Disease) 02/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Hepatitis 01/2021
1	Autoimmune Pancreatitis 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2020
1	Cutaneous Lupus Erythematosus 06/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Ichthyosis (Xeroderma) 01/2020
1	Leg Ulcer 11/2019
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 10/2019
1	Dyschromatosis symmetrica hereditaria 1 12/2018
1	Eosinophilia 08/2018
1	Ageusia (Hypogeusia) 08/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Fasciitis (Fascitis) 01/2018
1	Adult-Onset Still's Disease 10/2017
1	Arthritis (Polyarthritis) 01/2017
1	Iridocyclitis 01/2017

Drug/Important Bio-Agent (IBA)

43	AutoantibodiesIBA 02/2022 - 10/2004
31	AntibodiesIBA 11/2022 - 10/2004
13	Proteins (Proteins, Gene)FDA Link 02/2022 - 10/2004
6	lens epithelium-derived growth factorIBA 01/2013 - 11/2004
4	EnzymesIBA 02/2017 - 06/2013
4	AutoantigensIBA 01/2016 - 01/2007
3	Ligases (Synthetase)IBA 02/2022 - 08/2016
3	Mi-2 antibodiesIBA 12/2016 - 04/2011
3	transcriptional intermediary factor 1IBA 12/2016 - 08/2012
2	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2021 - 01/2021
2	DesmocollinsIBA 08/2020 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2019 - 08/2018
2	UbiquitinIBA 09/2015 - 06/2013
2	Immunoglobulin G (IgG)IBA 09/2011 - 11/2004
2	Endoplasmic Reticulum Chaperone BiPIBA 09/2011 - 09/2009
2	AntigensIBA 04/2009 - 02/2005
1	Branched-Chain Amino AcidsIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 02/2022
1	Glycoproteins (Glycoprotein)IBA 02/2022
1	Adalimumab (Humira)FDA Link 06/2021
1	Ustekinumab (CNTO 1275)FDA Link 02/2021
1	Janus Kinase 1IBA 01/2021
1	Rituximab (Mabthera)FDA Link 10/2020
1	belimumabIBA 10/2020
1	Immunoglobulins (Immunoglobulin)IBA 10/2020
1	Desmoglein 3IBA 08/2020
1	pembrolizumabIBA 06/2020
1	Hormones (Hormone)IBA 03/2020
1	Estrogen ReceptorsIBA 03/2020
1	Short Chain Dehydrogenase-ReductasesIBA 01/2020
1	Linoleic Acid (Linoleate)IBA 01/2020
1	CeramidesIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	LipidsIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Antiphospholipid AntibodiesIBA 11/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2019
1	Sunscreening Agents (Sunscreens)IBA 12/2018
1	Zonisamide (Zonegran)FDA LinkGeneric 08/2018
1	Signal Recognition ParticleIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 10/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	anticentromere antibodyIBA 01/2017

Therapy/Procedure

3	Therapeutics 05/2022 - 10/2013